Janux Therapeutics (NASDAQ:JANX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Janux Therapeutics (JANX) operate in?

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Janux Therapeutics Stock (NASDAQ: JANX) stock price, news, charts, stock research, profile.

Open	$56.37
Close	$56.83
Volume / Avg.	1.25M / 967.18K
Day Range	$55.63 - $59.72
52 Wk Range	7.79 - 71.71
Market Cap	$3.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	13.63%
Days to Cover	6.81

Recent News

SoundHound, Asana And Victorias Secret Are Among Top 10 Mid Cap Gainers Last Week (Dec 2-Dec 6): Are The Others In Your Portfolio?

Top performing mid-cap stocks last week: NBIS, SOUN, BTDR, ASAN, JANX, NVCR, KC, VSCO, ZETA, FIVE. Analysts raise price forecasts for these stocks.

Lekha Gupta

Janux Therapeutics' Prostate Cancer Trial Data Exceeds Investor Expectations: Analyst

Janux Therapeutics reports updated clinical data for JANX007, highlighting significant efficacy, safety, and durability in advanced prostate cancer patients.

Vandana Singh

AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$56.37
Close	$56.83
Volume / Avg.	1.25M / 967.18K
Day Range	$55.63 - $59.72
52 Wk Range	7.79 - 71.71
Market Cap	$3.33B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	13.63%
Days to Cover	6.81

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Janux Therapeutics (JANX) stock?

You can purchase shares of Janux Therapeutics (NASDAQ:JANX) through any online brokerage.

View our list of the best stock brokerages

Who are Janux Therapeutics (JANX) competitors?

Other companies in Janux Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA) and MoonLake (NASDAQ:MLTX).

What is the forecast, or price target, for Janux Therapeutics (JANX) stock?

Janux Therapeutics has a consensus price target of $83.09.

What is the current price for Janux Therapeutics (JANX)?

The stock price for Janux Therapeutics (NASDAQ: JANX) is $56.83 last updated December 20, 2024 at 4:04 PM EST.

Does Janux Therapeutics (JANX) pay a dividend?

There are no upcoming dividends for Janux Therapeutics.

When is Janux Therapeutics (NASDAQ:JANX) reporting earnings?

Janux Therapeutics’s Q4 earnings are confirmed for Friday, March 7, 2025.

Is Janux Therapeutics (JANX) going to split?

There is no upcoming split for Janux Therapeutics.

What sector and industry does Janux Therapeutics (JANX) operate in?

Janux Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Janux Therapeutics

Janux Therapeutics (JANX) Forecast